Medical devices, healthcare technology and the business of care
PMA approval · P110023

EVERFLEX SELF-EXPANDING PERIPHERAL STENT SYSTEM (EVERFLEX)

Medtronic Vascular, Inc. · Decision date Mar 7, 2012

MEDTECHLEDGER EXPLANATIONP110023

What did the FDA approve?

FDA records show approval of the EverFlex Self-Expanding Peripheral Stent System, not a separate supplement or a broader re-approval of a different device. The source statement names the device and gives its stated purpose, but it does not describe clinical outcomes, testing results, or any change to prior PMA scope beyond the approval entry itself.

The recorded intended use is narrow and technical: to improve luminal diameter for symptomatic de novo or restenotic lesions up to 180 mm in the native superficial femoral artery and/or proximal popliteal arteries, with reference vessel diameters of 4.5 to 7.5 mm. No other indication, patient selection detail, or performance claim is supplied in the provided text.

FDA approval order statement

APPROVAL FOR THE EVERFLEX SELF-EXPANDING PERIPHERAL STENT SYSTEM. THIS DEVICE IS INTENDED TO IMPROVE LUMINAL DIAMETER IN THE TREATMENT OF SYMPTOMATIC DE NOVO OR RESTENOTIC LESIONS UP TO 180MM IN LENGTH IN THE NATIVE SUPERFICIAL FEMORAL ARTERY (SFA) AND/OR PROXIMAL POPLITEAL ARTERIES WITH REFERENCE VESSEL DIAMETERS RANGING FROM 4.5 -7.5MM.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Mar 7, 2012

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P110023
Regulatory pathway
Premarket approval application
Product code
NIP
Decision code
APPR
Decision date
Mar 7, 2012
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: STENT, SUPERFICIAL FEMORAL ARTERY.

Product code
NIP
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P110023 received

    Application receipt date recorded by FDA.

  2. P110023 · FDA decision

    APPR

  3. P110023/S069 · Related supplement

    EverFlex Self-Expanding Peripheral Stent System; EverFlex Self-Expanding Peripheral Stent with Entrust Delivery Syste

  4. P110023/S070 · Related supplement

    EVERFLEX SELF-EXPANDING PERIPHERAL STENT SYSTEM (EVERFLEX)

Timeline entries are records held by MedtechLedger for P110023. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P110023

Explore the linked device profile

Other records with product code NIP

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Vascular, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
3033 Campus Dr., Plymouth, MN, 55441

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records